The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Perspective
Volume 349:1691-1692 October 30, 2003 Number 18
NextNext

HRPT2, a Marker of Parathyroid Cancer
Lee S. Weinstein, M.D., and William F. Simonds, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Shattuck, T. M.
-PubMed Citation
Primary hyperparathyroidism is a state of excess secretion of parathyroid hormone and hypercalcemia, often with skeletal and renal complications. The disease usually results from a single parathyroid adenoma. Less commonly, tumors occur in multiple parathyroid glands, and in these cases the disease may be familial. Familial primary hyperparathyroidism may occur in several genetically distinct disorders, including multiple endocrine neoplasia types 1 and 2A, the hyperparathyroidism–jaw tumor (HPT-JT) syndrome, and familial hypocalciuric hypercalcemia, or it can present as a solitary abnormality (as in familial isolated hyperparathyroidism).

(See Glossary.)

View this table:
[in this window]
[in a new window]
 

 
Primary hyperparathyroidism occurs in virtually all patients with multiple endocrine neoplasia type . . . [Full Text of this Article]


Source Information

From the Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Md.


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.